bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair
March 12, 2019 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
March 06, 2019 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
South Texas Veterans Health Care System Joins Test Validation Trial of bioAffinity’s CyPath® Lung
October 23, 2018 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the South Texas Veterans Health Care System (STVHCS), which is...
Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung
September 18, 2018 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
bioAffinity Technologies Welcomes Mohsin Y. Meghji to Board of Directors
July 31, 2018 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 31, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Mohsin...
bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung
July 17, 2018 14:40 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an...
bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
January 05, 2018 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
bioAffinity Technologies Welcomes New Board Members
November 29, 2017 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
bioAffinity Technologies Announces $4 Million Series A Funding
July 19, 2017 15:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 19, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early-stage cancer diagnostics and precision therapeutics, announced today that it raised...
City of San Antonio Invests in bioAffinity Technologies
March 09, 2017 19:02 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...